Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 known ✓ | P11511 | 1/20 | 0.47 |
| ▸ | PRKCI known ✓ | P41743 | 1/20 | 0.46 |
| ▸ | QPCT | Q16769 | 6/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | SOD1 | P00441 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CLK1 | P49759 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL19549172 | 1.00 | QPCT (0.53) | QPCTNPC1RAB9AATMALDH1A1 | |
| SCHEMBL291484 | 0.99 | QPCT (0.54) | QPCTNPC1RAB9AATMALDH1A1 | |
| SCHEMBL15793526 | 0.89 | QPCT (0.51) | QPCTNPC1RAB9AATMALDH1A1 | |
| SCHEMBL19923777 | 0.88 | QPCT (0.45) | QPCTNPC1RAB9AATMALDH1A1 | |
| 3-Aminophenol SCHEMBL15793122 | 0.87 | QPCT (0.49) | QPCTNPC1RAB9AATMALDH1A1 | |
| SCHEMBL548590 | 0.86 | QPCT (0.46) | QPCTNPC1RAB9AATMALDH1A1 | |
| SCHEMBL17351760 | 0.85 | QPCT (0.43) | QPCTNPC1RAB9AATMALDH1A1 | |
| SCHEMBL20263013 | 0.85 | QPCT (0.46) | QPCTALDH1A1KMT2AMEN1LMNA | |
| 1-Naphthol SCHEMBL14953678 | 0.84 | SOD1 (0.50) | QPCTNPC1RAB9AATMALDH1A1 | |
| SCHEMBL2452433 | 0.84 | QPCT (0.52) | QPCTPOLBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1726289-A2 | Dyeing composition for keratin fibres which contains a reducing agent | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-11-29 | — | — | EP | claimed |
| EP-1825884-B1 | Brightening and/or colouring agent with reduced potential for irritation | HENKEL AG & CO KGAA (DE) | 2017-08-16 | — | — | EP | disclosed |
| EP-1813260-B1 | Bleaching and/or colouring agent with reduced potential for irritation | HENKEL AG & CO KGAA (DE) | 2017-05-31 | — | — | EP | disclosed |
| EP-1813258-B1 | Bleaching and/or colouring agent with reduced potential for irritation | HENKEL AG & CO KGAA (DE) | 2017-04-19 | — | — | EP | disclosed |
| EP-1813259-B1 | Bleaching and/or colouring agent with reduced potential for irritation | HENKEL AG & CO KGAA (DE) | 2017-04-19 | — | — | EP | disclosed |
| EP-2012742-B1 | BLEACHING AND/OR COLOURING AGENTS CONTAINING PIPERIDONES | HENKEL AG & CO KGAA (DE) | 2014-03-19 | — | — | EP | disclosed |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | disclosed |
| EP-1917955-A2 | Performance enhanced cosmetic agent with purine and/or purine derivatives II | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-05-07 | — | — | EP | disclosed |
| EP-1905418-A2 | Hydrogen peroxide activation with N-heterocycles | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-04-02 | — | — | EP | disclosed |
| EP-1900355-A2 | Bleaching and/or dyeing agent with heterocyclic aldehydes | Henkel Kommanditgesellschaft auf Aktien (DE) | 2008-03-19 | — | — | EP | disclosed |
| EP-1825884-A2 | Brightening and/or colouring agent with reduced potential for irritation | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-29 | — | — | EP | disclosed |
| EP-1813259-A2 | Bleaching and/or colouring agent with reduced potential for irritation | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1813258-A2 | Bleaching and/or colouring agent with reduced potential for irritation | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1813260-A2 | Bleaching and/or colouring agent with reduced potential for irritation | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1813261-A2 | Bleaching method for keratinic fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1726289-A2 | Dyeing composition for keratin fibres which contains a reducing agent | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-11-29 | — | — | EP | disclosed |
| US-7081140-B2 | Developer components and their use for dyeing keratinic fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-07-25 | — | — | US | disclosed |
| US-20040255402-A1 | Developer components and their use for dyeing keratinic fibers | HENKEL AG & CO. KGAA (DE) | 2004-12-23 | — | — | US | disclosed |
| EP-1438294-A1 | DEVELOPER CONSTITUENTS AND THEIR USE FOR DYING KERATIN FIBERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003037875-A1 | DEVELOPER CONSTITUENTS AND THEIR USE FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040255402-A1 | Developer components and their use for dyeing keratinic fibers | KRT18, DSP, DSG1 | CYP19A1 4008/4885PRKCI 232/4885QPCT 2205/4885 |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | ASS1, SRM, COL1A1 | CYP19A1 372/4885PRKCI 3095/4885QPCT 3819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.